Valve Replacement Clinical Trials

34 recruitingLast updated: June 18, 2026

There are 34 actively recruiting valve replacement clinical trials across 28 countries. Studies span Not Applicable, Phase 3, Phase 4, Early Phase 1. Top locations include Chengdu, Sichuan, China, Fuzhou, Fujian, China, Beijing, Beijing Municipality, China. Updated daily from ClinicalTrials.gov.


Valve Replacement Trials at a Glance

34 actively recruiting trials for valve replacement are listed on ClinicalTrialsFinder across 6 cities in 28 countries. The largest study group is Not Applicable with 14 trials, with the heaviest enrollment activity in Chengdu, Fuzhou, and Beijing. Lead sponsors running valve replacement studies include Insel Gruppe AG, University Hospital Bern, Niguarda Hospital, and Second Affiliated Hospital, School of Medicine, Zhejiang University.

Browse valve replacement trials by phase

Treatments under study

About Valve Replacement Clinical Trials

Looking for clinical trials for Valve Replacement? There are currently 3 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Valve Replacement trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Valve Replacement clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 34 trials

Recruiting
Not Applicable

Evaluation of the Safety and Effectiveness of CHORDS® Cerebral Protection System During TAVR: DUET Trial

Transcatheter Aortic Valve Replacement (TAVR)Cerebral Vascular Accident (CVA)/Stroke
Resonova (Shanghai) Medtech Limited240 enrolled15 locationsNCT07648693
Recruiting

Transcatheter Mitral and Tricuspid Interventions: a Cardiac Magnetic Resonance Study

Mitral InsufficiencyTranscatheter Aortic Valve Replacement
Centro Cardiologico Monzino250 enrolled1 locationNCT07370467
Recruiting

Prospective Validation of a Pre-Specified Algorithm for the Management of Conduction Disturbances Following TAVR

Transcatheter Aortic Valve ReplacementConduction DisturbancesPermanent Pacemaker Implantation
Centre de Recherche de l'Institut Universitaire de Cardiologie et de Pneumologie de Quebec2,000 enrolled1 locationNCT04139616
Recruiting
Early Phase 1

Replacement of the Native Mitral Valve Using the ReValve System

Mitral Valve Replacement
ReValve Solutions Inc.25 enrolled2 locationsNCT07601269
Recruiting

Abbott Cephea Mitral Valve Disease Registry

Mitral RegurgitationMitral StenosisMitral Valve Disease+4 more
Abbott Medical Devices1,000 enrolled22 locationsNCT07069673
Recruiting
Not Applicable

Coronary Artery Disease Assessment Strategies in TAVI Patients

Coronary Artery DiseaseTranscatheter Aortic Valve ReplacementHeart Disease Risk Factors
Insel Gruppe AG, University Hospital Bern546 enrolled1 locationNCT06559332
Recruiting
Not Applicable

Prolonged Chest Tube Treatment to Reduce Rates of Atrial Fibrillation Following Cardiac Surgery

Coronary Arterial Disease (CAD)Valve ReplacementAortic Surgery
Region Skane624 enrolled1 locationNCT06800781
Recruiting
Phase 4

Patient Quality of Recovery After TAVR With Different Sedation Regimens

Aortic Valve StenosisTranscatheter Aortic Valve Replacement (TAVR)
David Lyubashevsky126 enrolled1 locationNCT07556523
Recruiting

Ischemic And Bleeding Risk Assessment After TAVR

Aortic Valve StenosisTranscatheter Aortic Valve Replacement
Niguarda Hospital2,500 enrolled12 locationsNCT06000943
Recruiting

COronary Re-engageMent aFter randOm NavitoR alignmenT (COMFORT STUDY)

Aortic Valve StenosisTranscatheter Aortic Valve Replacement
Niguarda Hospital100 enrolled1 locationNCT05779787
Recruiting
Not Applicable

Robotic Transjugular Transcatheter Tricuspid Valve Replacement

Tricuspid Regurgitation (TR)Transcatheter Valve ReplacementValvular Heart Diseases
Prince of Wales Hospital, Shatin, Hong Kong10 enrolled1 locationNCT07516145
Recruiting

Valve Performance of the SAPIEN 3 Ultra RESILIA Valve: A Prospective Registry With Central Echocardiography Analysis.

Aortic Valve StenosisTranscatheter Aortic Valve Replacement
Institut universitaire de cardiologie et de pneumologie de Québec, University Laval150 enrolled1 locationNCT06420830
Recruiting
Not Applicable

Frequency of Electrical Acupoint Stimulation on Hypotension in TAVR Patients

Transcatheter Aortic Valve Replacement (TAVR)Anesthesia Inductionhemodynamic stability+1 more
Air Force Military Medical University, China150 enrolled1 locationNCT07365345
Recruiting
Not Applicable

Phenotyping Left Ventricle Failure With Hemodynamic Biomarkers From 4D Flow Magnetic Resonance Imaging

Aortic Valve StenosisLeft Ventricle FunctionTranscatheter Aortic Valve Replacement (TAVR)
IRCCS Policlinico S. Donato190 enrolled2 locationsNCT07455292
Recruiting

Mosaic Mitral Valve: Long-Term Outcomes in Patients Under 65

Valve Disease, HeartValve ReplacementValve Heart Stenosis+1 more
Michael Moront300 enrolled1 locationNCT06917586
Recruiting
Phase 4

TRanscAtheter TreatMent of PurE Aortic Regurgitation With VitaFlow Liberty System

AORTIC VALVE DISEASESTranscatheter Aortic Valve Replacement (TAVR)aortic regurgitation
Ruijin Hospital120 enrolled4 locationsNCT06818084
Recruiting
Not Applicable

Comparative Research of Y-Incision vs. Standard Techniques for Aortic Root EnLargement

Severe Aortic Valve DiseaseAortic Valve Replacement (AVR)Small Aortic Annulus
willner nadav MD90 enrolled1 locationNCT07368322
Recruiting
Not Applicable

Comparison of Single vs. Dual Perclose Devices for Large-Bore Access Closure in TAVR

Transcatheter Aortic Valve Replacement
Wake Forest University Health Sciences300 enrolled1 locationNCT06871774
Recruiting
Not Applicable

A Single Centre Study Comparing Continuous Interstitial Fluid Lactate Detection to Standard Measurements of Lactate in Patients Undergoing Elective Coronary Artery Bypass Graft Surgery and/or Valve Replacement.

valve surgeryCoronary Artery BypassCardiovascular+4 more
Queen Mary University of London50 enrolled1 locationNCT06602336
Recruiting
Phase 3

Low INR to Minimize Bleeding With Mechanical Valves Trial

Bleeding Post-mechanical Valve ReplacementThromboembolism Post-mechanical Valve Replacement
Population Health Research Institute2,625 enrolled35 locationsNCT03636295